1 May 2024 false Taxfiler 2024.6 11963343 business:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 11963343 2024-04-30 11963343 2024-05-01 2025-04-30 11963343 business:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 11963343 business:FilletedAccounts 2024-05-01 2025-04-30 11963343 2025-04-30 11963343 business:Director1 2024-05-01 2025-04-30 11963343 business:Director3 2024-05-01 2025-04-30 11963343 business:RegisteredOffice 2024-05-01 2025-04-30 11963343 2024-04-30 11963343 core:WithinOneYear 2025-04-30 11963343 core:WithinOneYear 2024-04-30 11963343 core:AfterOneYear 2025-04-30 11963343 core:AfterOneYear 2024-04-30 11963343 core:ShareCapital core:PreviouslyStatedAmount 2025-04-30 11963343 core:ShareCapital core:PreviouslyStatedAmount 2024-04-30 11963343 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-04-30 11963343 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-04-30 11963343 core:PreviouslyStatedAmount 2025-04-30 11963343 core:PreviouslyStatedAmount 2024-04-30 11963343 business:SmallEntities 2024-05-01 2025-04-30 11963343 countries:EnglandWales 2024-05-01 2025-04-30 11963343 core:ComputerEquipment 2024-05-01 2025-04-30 11963343 core:LandBuildings 2024-04-30 11963343 core:ComputerEquipment 2024-04-30 11963343 core:LandBuildings 2025-04-30 11963343 core:ComputerEquipment 2025-04-30 11963343 core:LandBuildings 2024-05-01 2025-04-30 11963343 business:OrdinaryShareClass1 2024-05-01 2025-04-30 11963343 business:OrdinaryShareClass1 2023-05-01 2024-04-30 11963343 business:Director3 1 2024-05-01 2025-04-30 11963343 business:Director3 1 2024-04-30 11963343 business:Director3 1 2025-04-30 11963343 2023-05-01 2024-04-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 11963343 (England and Wales)
SWM PHARMA SOLUTIONS LIMITED Unaudited accounts for the year ended 30 April 2025
SWM PHARMA SOLUTIONS LIMITED Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
SWM PHARMA SOLUTIONS LIMITED Company Information for the year ended 30 April 2025
Directors
Waseem Nawaz Ashtons Healthcare Solutions Ltd
Company Number
11963343 (England and Wales)
Registered Office
833 Moss Bank Way Bolton BL1 5SN
Accountants
Olaando Consulting Ltd 7 Bell Yard London WC2A 2JR
- 3 -
SWM PHARMA SOLUTIONS LIMITED Statement of financial position as at 30 April 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
311,825
313,870
Investments
5
37,150
37,150
348,975
351,020
Current assets
Inventories
-
20,000
Debtors
6
159,445
18,389
Cash at bank and in hand
140,225
225,345
299,670
263,734
Creditors: amounts falling due within one year
7
(46,120)
(57,064)
Net current assets
253,550
206,670
Total assets less current liabilities
602,525
557,690
Creditors: amounts falling due after more than one year
8
(123,329)
(193,329)
Net assets
479,196
364,361
Capital and reserves
Called up share capital
9
100
100
Profit and loss account
479,096
364,261
Shareholders' funds
479,196
364,361
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 27 October 2025 and were signed on its behalf by
Waseem Nawaz Director Company Registration No. 11963343
- 4 -
SWM PHARMA SOLUTIONS LIMITED Notes to the Accounts for the year ended 30 April 2025
1
Statutory information
SWM PHARMA SOLUTIONS LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11963343. The registered office is 833 Moss Bank Way , Bolton , BL1 5SN.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
Government grants
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
33% Straight line
- 5 -
SWM PHARMA SOLUTIONS LIMITED Notes to the Accounts for the year ended 30 April 2025
4
Tangible fixed assets
Land & buildings
Computer equipment
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 May 2024
309,780
9,607
319,387
At 30 April 2025
309,780
9,607
319,387
Depreciation
At 1 May 2024
-
5,517
5,517
Charge for the year
-
2,045
2,045
At 30 April 2025
-
7,562
7,562
Net book value
At 30 April 2025
309,780
2,045
311,825
At 30 April 2024
309,780
4,090
313,870
5
Investments
Other investments
£
Valuation at 1 May 2024
37,150
Valuation at 30 April 2025
37,150
6
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
28,445
18,389
Other debtors
131,000
-
159,445
18,389
7
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
39,313
55,984
Other creditors
5,727
-
Accruals
1,080
1,080
46,120
57,064
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
48,359
48,359
Loans from directors
74,970
144,970
123,329
193,329
- 6 -
SWM PHARMA SOLUTIONS LIMITED Notes to the Accounts for the year ended 30 April 2025
9
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
10
Loans to directors
Brought Forward
Advance/ credit
Repaid
Carried Forward
£
£
£
£
Ashtons Healthcare Solutions Ltd
Loans from Director
144,970
-
70,000
74,970
144,970
-
70,000
74,970
11
Average number of employees
During the year the average number of employees was 14 (2024: 14).
- 7 -